Skip to content

Author

D. Mehta

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Multicomponent vaccination against seasonal influenza and COVID-19: a strategy to address the continued global burden of disease in adults.

Promising multicomponent influenza-COVID-19 vaccine candidates currently being evaluated in clinical trials may represent an important advancement in adult immunization strategy, and a meaningful opportunity to strengthen protection against two of the most consequential respiratory pathogens worldwide.

W. Schaffner, S. Gravenstein, S. Kissler et al. · 0 citations
Open access Aug 2026

Indirect comparison of mRNA-1010 versus enhanced influenza vaccines in adults aged 65 years and older during the 2024-2025 US influenza season.

MRNA-1010, a new mRNA-based influenza vaccine, was shown to be comparable to currently licensed EVs among older adults ≥65 years against medically attended influenza outcomes, and provides an additional comparable option to existing EVs to help further reduce severe influenza disease burden.

K. Joshi, A. Situ, D. Mehta et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.